Dr. Christopher Boerner is board chair and chief executive officer at Bristol Myers Squibb. Prior to assuming his current role, he served as executive vice president, chief operating officer and chief executive officer designate from April to November 2023. He joined the company in February 2015.
From 2010 to 2015, Chris held leadership roles of increasing responsibility at Seattle Genetics, Inc. From 2002 to 2010, he served in marketing leadership roles at Genentech, a member of the Roche Group, focused on strategy, development and commercialization across multiple oncology products and immunology. Earlier in his career, Chris worked for McKinsey & Company, serving global pharmaceutical and biotechnology clients. Chris received his PhD and MA in business administration from the Haas School of Business at the University of California, Berkeley, and holds a BA in economics and history from Washington University in St. Louis.
You can learn more about Dr. Christopher Boerner on his full bio page.